California State Teachers Retirement System Graphite Bio, Inc. Transaction History

California State Teachers Retirement System

$80.4 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.24 - $2.66 $3,516 - $4,176	-1,570 Reduced 25.39%	4,613 $12,000
Q3 2023 Nov 14, 2023	SELL	$2.18 - $2.77 $6,843 - $8,695	-3,139 Reduced 33.67%	6,183 $15,000
Q2 2023 Aug 21, 2023	BUY	$2.47 - $3.38 $23,025 - $31,508	9,322 New	9,322 $24,000
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $27,028 - $66,054	-12,630 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.1 - $13.06 $19,522 - $49,993	3,828 Added 43.49%	12,630 $64,000
Q4 2021 Feb 15, 2022	BUY	$8.41 - $16.71 $185 - $367	22 Added 0.25%	8,802 $109,000
Q3 2021 Nov 15, 2021	BUY	$15.81 - $28.39 $138,811 - $249,264	8,780 New	8,780 $144,000

Others Institutions Holding GRPH

# of Institutions

Shares Held

637K

Call Options Held

Put Options Held

View Full List

About Graphite Bio, Inc.

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

More about GRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account